Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajeev Chavda

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2020
Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation studyJonathan I Silverberg, Donald Lei, Muhammad Yousaf, et al.
Dermatology and Therapy|October 15, 2023
Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled StudyStephen Schleicher, Angela Moore, Elyse Rafal, et al.
International Journal of Dermatology|April 29, 2024
Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentationAndrew Alexis, James Q Del Rosso, Seth Forman, et al.
Journal of the American Academy of Dermatology|June 1, 2019
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosaceaMartin Schaller, Lajos Kemény, Blanka Havlickova, et al.
Dermatology and Therapy|January 12, 2024
Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled StudyStephen Schleicher, Angela Moore, Elyse Rafal, et al.
International Journal of Dermatology|April 21, 2024
A review of the topical management of acne and its associated sequelae in the Asia-Pacific region with a spotlight on trifaroteneJo-Ann See, Rajeev Chavda, Khen M Kon, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 17, 2020
Association of itch triggers with atopic dermatitis severity and course in adultsJonathan I Silverberg, Donald Lei, Muhammad Yousaf, et al.
Journal of the American Academy of Dermatology|May 20, 2020
Association of atopic dermatitis severity with cognitive function in adultsJonathan I Silverberg, Donald Lei, Muhammad Yousaf, et al.
Journal of the American Academy of Dermatology|January 23, 2021
Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitisGabrielle Schwartzman, Donald Lei, Muhammad Yousaf, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|December 4, 2020
Measurement Properties of Patient Health Questionnaire 9 and Patient Health Questionnaire 2 in Adult Patients With Atopic DermatitisJonathan I Silverberg, Brad Lee, Donald Lei, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2020
Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation studyJonathan I Silverberg, Donald Lei, Muhammad Yousaf, et al.
Dermatology and Therapy|October 15, 2023
Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled StudyStephen Schleicher, Angela Moore, Elyse Rafal, et al.
International Journal of Dermatology|April 29, 2024
Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentationAndrew Alexis, James Q Del Rosso, Seth Forman, et al.
Journal of the American Academy of Dermatology|June 1, 2019
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosaceaMartin Schaller, Lajos Kemény, Blanka Havlickova, et al.
Dermatology and Therapy|January 12, 2024
Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled StudyStephen Schleicher, Angela Moore, Elyse Rafal, et al.
International Journal of Dermatology|April 21, 2024
A review of the topical management of acne and its associated sequelae in the Asia-Pacific region with a spotlight on trifaroteneJo-Ann See, Rajeev Chavda, Khen M Kon, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 17, 2020
Association of itch triggers with atopic dermatitis severity and course in adultsJonathan I Silverberg, Donald Lei, Muhammad Yousaf, et al.
Journal of the American Academy of Dermatology|May 20, 2020
Association of atopic dermatitis severity with cognitive function in adultsJonathan I Silverberg, Donald Lei, Muhammad Yousaf, et al.
Journal of the American Academy of Dermatology|January 23, 2021
Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitisGabrielle Schwartzman, Donald Lei, Muhammad Yousaf, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|December 4, 2020
Measurement Properties of Patient Health Questionnaire 9 and Patient Health Questionnaire 2 in Adult Patients With Atopic DermatitisJonathan I Silverberg, Brad Lee, Donald Lei, et al.
Pageof 6